CVS Health has seen a 77% increase in shares this year due to improved financial results. Despite past struggles, the company continues to make progress in fixing underperforming areas. CVS aims to reduce costs and focus on profitable growth to maintain momentum through 2026.
The company faced challenges with rising expenses in its Medicare Advantage business, leading to shrinking margins and earnings. CVS had difficulty forecasting rising medical costs, causing it to lower guidance. However, recent efforts to cut expenses are showing positive results, with third-quarter revenue exceeding expectations.
CVS announced a plan to save $2 billion by closing stores and reducing its workforce. This initiative, along with other cost-saving measures, has led to stronger financial results this year. Third-quarter revenue hit a company record of $102.9 billion, up 7.8% from the same period in 2024.
Adjusted operating income rose 35.8% year over year, with non-GAAP earnings per share up nearly 47%. CVS increased its guidance for fiscal year 2025, indicating strong performance. The company’s shares remain attractively valued and show potential for long-term growth.
CVS plans to scale back its Medicare Advantage and ACA health insurance operations to improve profitability. The company’s vast pharmacy network and health services offer a strong competitive advantage. With an aging population driving increased healthcare spending, CVS is poised for long-term success.
With a forward yield of 3.4% and a reasonable cash payout ratio, CVS is a solid option for dividend seekers. Despite challenges, the company’s strategic adjustments and strong performance make it an attractive long-term investment.
The Motley Fool Stock Advisor team highlighted 10 stocks for investors to consider, with CVS Health not making the list. This exclusive list has historically produced substantial returns, making it a valuable resource for individual investors.
Read more at Yahoo Finance: Can CVS Health Maintain Its Growth Through the End of 2025?